Product Added to Cart!
$131.00

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI14891_100_MG
Chem Impex
Get Bulk Quote

Product Information

Product Name
H-a-Me-L-Leucine
Brand Name
Chem Impex
Product Number
14891
CAS
105743-53-1
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
446181
IUPAC Name
(2S)-2-amino-2,4-dimethylpentanoic acid
InChI Key
ARSWQPLPYROOBG-ZETCQYMHSA-N
SMILES
CC(C)CC@@(C)(C(=O)O)N

Description

H-a-Me-L-Leucine is widely utilized in research focused on:

Protein Synthesis: This compound serves as a vital building block in the synthesis of proteins, particularly in studies related to muscle growth and repair, making it essential for sports nutrition and bodybuilding.

Pharmaceutical Development: It is used in the formulation of peptide-based drugs, enhancing the efficacy of treatments for various conditions, including metabolic disorders and muscle-wasting diseases.

Biotechnology: H-a-Me-L-Leucine plays a crucial role in the production of recombinant proteins, which are important for vaccine development and therapeutic applications.

Food Industry: This compound is explored as a dietary supplement to improve amino acid profiles in food products, catering to health-conscious consumers seeking enhanced nutrition.

Research on Metabolism: It is utilized in metabolic studies to understand the role of branched-chain amino acids in energy production and their impact on overall health, providing insights for nutritional science.

References Data Source From Pubchem

Immobilized acyl-transfer molecular reactors enable the solid-phase synthesis of sterically hindered peptides

Publication Name: Nature Chemistry
Publication Date: 2025-08-06
DOI: 10.1038/s41557-025-01896-8

Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide

Publication Name: Cell Discovery
Publication Date: 2024-07-17
DOI: 10.1038/s41421-024-00700-0

A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity

Publication Name: European Journal of Clinical Pharmacology
Publication Date: 2024-02-17
DOI: 10.1007/s00228-024-03646-0

Structural insight into the substrate specificity of PLP fold type IV transaminases

Publication Name: Applied Microbiology and Biotechnology
Publication Date: 2020-01-27
DOI: 10.1007/s00253-020-10369-6

Photochemistry and Photoreactions of Organic Molecules in Space

Publication Name: Advances in Astrobiology and Biogeophysics
Publication Date: 2018-10-02
DOI: 10.1007/978-3-319-96175-0_10